Publication Name	World Journal of Clinical Cases
Manuscript ID	87739
Country	China

Received	2023-08-25 05:28
Peer-Review Started	2023-08-25 05:30
To Make the First Decision
Return for Revision	2023-12-07 01:02
Revised	2023-12-12 17:54
Second Decision	2023-12-19 02:54
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-12-19 08:52
Articles in Press	2023-12-19 08:52
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-12-21 09:03
Publish the Manuscript Online	2024-01-02 09:08

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Hematology
Manuscript Type	Case Report
Article Title	Azacitidine maintenance therapy for blastic plasmacytoid dendritic cell neoplasm allograft: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Li-Li Tao, Hui-Ting Wen, Zi-Yi Wang, Juan Cheng and Li Zhao
Funding Agency and Grant Number
Corresponding Author	Li Zhao, Doctor, MD, Chief Doctor, Department of Hematology, The First Hospital of Lanzhou University, No. 1 Donggangxi Road, Chengguan District, Lanzhou 730000, Gansu Province, China. zhaoli@lzu.edu.cn
Key Words	Blastic plasmacytoid dendritic cell neoplasm; Azacitidine; Allogeneic hematopoietic stem cell transplantation; Maintenance therapy; Case report
Core Tip	Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematological tumor with cutaneous invasion as the first clinical manifestation, as well as lymph nodes, soft tissues, peripheral blood, and bone marrow involvement. The first recommended treatment option is allogeneic hematopoietic stem cell transplantation, but there is still a high recurrence rate after transplantation. We present a case of azacitidine maintenance treatment to prevent BPDCN allograft relapse in our center.
Publish Date	2024-01-02 09:08
Citation	Tao LL, Wen HT, Wang ZY, Cheng J, Zhao L. Azacitidine maintenance therapy for blastic plasmacytoid dendritic cell neoplasm allograft: A case report. World J Clin Cases 2024; 12(1): 136-141
URL	https://www.wjgnet.com/2307-8960/full/v12/i1/136.htm
DOI	https://dx.doi.org/10.12998/wjcc.v12.i1.136

Full Article (PDF)	WJCC-12-136-with-cover.pdf
Full Article (Word)	WJCC-12-136.docx
CARE Checklist–2016	87739-CARE Checklist (2016).pdf
Manuscript File	87739_Auto_Edited-YJP.docx
Answering Reviewers	87739-Answering reviewers.pdf
Audio Core Tip	87739-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	87739-Conflict-of-interest statement.pdf
Copyright License Agreement	87739-Copyright license agreement.pdf
Signed Consent for Treatment Form(s) or Document(s)	87739-Informed consent statement.pdf
Non-Native Speakers of English Editing Certificate	87739-Language certificate.pdf
Peer-review Report	87739-Peer-review(s).pdf
Scientific Misconduct Check	87739-Bing-Li L-2.png
Scientific Editor Work List	87739-Scientific editor work list.pdf